UPenn Has Promising Early Results Of New Flu Vaccine

By CBS3 Staff

November 28, 2022

With flu on the rise, the University of Pennsylvania had some promising early results of an experimental vaccine.

Scientists at UPenn tested a vaccine made from all known influenza subtypes, using the same mRNA technology as the Pfizer and Moderna COVID-19 vaccines.

The study shows the vaccine triggers a quick memory immune response that can adapt to new viral strains.

Click https://www.cbsnews.com/philad... for a CBS News video report.

CBS Local Digital Media personalizes the global reach of CBS-owned and operated television and radio stations with a local perspective.